Stent News and Research RSS Feed - Stent News and Research

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.
New technique may reduce need for amputation in patients with critical limb ischemia

New technique may reduce need for amputation in patients with critical limb ischemia

A new imaging technique could reduce the need for amputation in patients with critical limb ischemia, according to a study publised today in the scientific journal JACC. [More]
TCAR procedure offers potentially safer method for high-risk stroke patients

TCAR procedure offers potentially safer method for high-risk stroke patients

The carotid arteries supply oxygenated blood to the brain. Every year, more than 300,000 people in the United States are diagnosed with blockages, or plaques, in their carotid artery. When these arteries become blocked due to plaque build-up, an individual is at high risk for a stroke if the plaque ruptures and flows to the brain. [More]
New study finds efficacy of novel intravenous blood thinner in women

New study finds efficacy of novel intravenous blood thinner in women

Percutaneous coronary intervention (PCI) is a staple of modern day medicine in which cardiologists place a stent in a blood vessel around the heart in order to restore blood flow in people with heart disease. Blood thinners allow for the procedure to be completed with a reduced risk of certain complications such as clots. [More]
QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announce today the release of the initial results from the first-in-human study of its unique drug-coated balloon, Chocolate Heart. [More]
Scientists develop a method for cell replacement in diseased vessels

Scientists develop a method for cell replacement in diseased vessels

In industrialized countries, a particularly high number of people suffer from arteriosclerosis -- with fatal consequences: Deposits in the arteries lead to strokes and heart attacks. A team of researchers under the leadership of the University of Bonn has now developed a method for guiding replacement cells to diseased vascular segments using nanoparticles. [More]
Penn study explores bleeding complications linked to cardiac stent placement techniques

Penn study explores bleeding complications linked to cardiac stent placement techniques

More than 375,000 American each year experience a heart attack, during which blood flow to a part of the heart is impeded by blocked arteries. Physicians often treat patients with stents, which prop open the arteries to allow blood to flow again. They use two approaches to place stents: transradial, or entry of the catheter which delivers the stent through the wrist, or transfemoral, in which the catheter is placed through the groin. [More]
Study examines whether treating multiple narrowed arteries has adverse effect on the heart

Study examines whether treating multiple narrowed arteries has adverse effect on the heart

A new study has examined the effects on the heart of treating multiple narrowed arteries - rather than just one - at the time of a heart attack. [More]
Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Treatment with the antiplatelet agent prasugrel does not significantly reduce the rate of pain crises or severe lung complications in children with sickle cell disease, according to a report published in the New England Journal of Medicine describing one of the largest and most geographically diverse international clinical trials on sickle cell disease to date. [More]

Medinol introduces NIRxcell CoCr Stent System to coronary marketplace

During the recent 2015 Transcatheter Cardiovascular Therapeutics Meeting held in San Francisco, CA, Medinol Ltd. continued to introduce novel stent solutions to the coronary marketplace. During a satellite symposium, "The BioNIR eDES: The Role of Uniformity in Stent Design to Minimize Restenosis", a renowned physician panel discussed the key attributes of the currently available Medinol NIRxcell CoCr Coronary Stent System and the Medinol eDES Coronary Stent System (in trials, not FDA/CE Mark approved). [More]
Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. [More]

Review of haemodynamics in stent development shows spiral flow may be key to improving peripheral arterial stent performance

Vascular Flow Technologies, the medical device company using proprietary Spiral Laminar Flow (SLF™) technology to replicate natural blood flow for enhanced patient outcomes, today announces that 'Haemodynamics and Flow Modification Stents for Peripheral Arterial Disease: A Review’, co-authored by VFT’s non-executive Medical Director Graeme Houston, has been published in the Annals of Biomedical Engineering. The paper reviews the importance of haemodynamics in stent development as a method of improving patency and longevity of the stent. [More]
Wyss Institute, UMass team up to develop drug-device combination for treating blood clots in stroke patients

Wyss Institute, UMass team up to develop drug-device combination for treating blood clots in stroke patients

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke. [More]
Frost & Sullivan honours recipients of 2015 Excellence in Best Practices Awards

Frost & Sullivan honours recipients of 2015 Excellence in Best Practices Awards

On Thursday, October 22, Frost & Sullivan honoured recipients of its 2015 Excellence in Best Practices Awards Banquet in Monaco. With a festive ambiance and exciting Awards, the event brought together top executives to celebrate their success. [More]
Bolton Medical reports first commercial implant of TREO Abdominal Stent-Graft System

Bolton Medical reports first commercial implant of TREO Abdominal Stent-Graft System

Bolton Medical, a subsidiary of the WerfenLife Company, announced the first commercial implant of the TREO Abdominal Stent-Graft System by Professor Giovanni Torsello, MD, Director of the Center for Vascular and Endovascular Surgery at St. Franciscus Hospital Muenster in Munster, Germany. [More]
LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, announced today that the LEADERS FREE clinical trial demonstrated superior safety and efficacy for BioFreedom compared with a bare-metal stent (BMS). [More]
Boston Scientific closes additional financing with MValve Technologies

Boston Scientific closes additional financing with MValve Technologies

Boston Scientific Corporation today announced that it has closed on an additional round of financing with MValve Technologies Ltd., a developer of a percutaneous mitral valve replacement system, designed to work with the Boston Scientific LOTUS Valve, creating a unique mitral regurgitation (MR) treatment solution. [More]
New approach helps create virtual models for treating abdominal aortic aneurysms

New approach helps create virtual models for treating abdominal aortic aneurysms

Virtual models can be created in the angiography room thanks to an approach developed by researchers at the University of Montreal Hospital Research Centre and the university's departments of radiology, radiation oncology, and nuclear medicine. The latest advances were presented by Dr. Gilles Soulez at the Cardiovascular and Interventional Radiology Society of Europe conference on September 27, 2015. [More]

Novel prosthetic heart valve developed for treatment of mitral regurgitation

A team of researchers from the National University of Singapore (NUS) has developed a novel prosthetic heart valve, known as VeloX, which can be implanted through a small incision for the treatment of a serious heart valve disorder called mitral regurgitation. This is a condition in which the mitral valve on the left side of the heart does not close properly. The device is particularly beneficial to patients who are of high surgical risk or are unsuitable for existing clinical interventions. [More]

Medinol announces completion of enrollment in BIONICS trial to evaluate effectiveness of eDES

Medinol, a developer of Interventional Cardiology devices, announced today the completion of enrollment in its BIONICS trial, a global, prospective, randomized, multicenter, clinical trial designed to evaluate the safety and effectiveness of a new Coronary Stent System, the first ever elastomeric Drug Eluting Stent or eDES. [More]
Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Using integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya Das

Pancreatic cystic neoplasms, or PCNs, are a subset of all pancreatic cysts that are found on the pancreas. PCNs are neoplastic cysts that span a biological spectrum from benign to malignant. [More]
Advertisement